Centronic, a new acquisition for Exosens

With the acquisition of Centronic, a leading British company in radiation detection solutions, Exosens is pursuing its development strategy and consolidating its position in nuclear instrumentation. In particular, this merger will enable the Group to expand into the market for small modular reactors, and to supply high-end detectors for the nuclear market. Congratulations to Jérôme Cerisier and his teams for this new acquisition, which gives the Group the means to become a European leader in this field.